Nadine Mayasi Ngongo1, Hippolyte Situakibanza Nani-Tuma2, Marcel Mbula Mambimbi2, Murielle Longokolo Mashi2, Ben Bepouka Izizag2, Faustin Kitetele Ndolumingu2, Nathalie Maes3, Michel Moutschen4,5, Gilles Darcis6. 1. Department of Internal Medicine, Infectious and Tropical Diseases, University Clinics of Kinshasa, Kinshasa, Democratic Republic of the Congo. nadiamayas02@gmail.com. 2. Department of Internal Medicine, Infectious and Tropical Diseases, University Clinics of Kinshasa, Kinshasa, Democratic Republic of the Congo. 3. Biostatistics and Medico-economic Information Department, University Hospital of Liege, Liège, Belgium. 4. Department of Internal Medicine and Infectious Diseases, Liège University Hospital, Liège, Belgium. 5. AIDS reference laboratory, University of Liège, Liège, Belgium. 6. Department of Internal Medicine and Infectious Diseases, Liège University Hospital, Liège, Belgium. gdarcis@chuliege.be.
Abstract
INTRODUCTION: Late presentation for HIV care is a well-described issue for the success of ART outcomes and the cause of higher morbidity, mortality and further transmission. Monitoring the level of late presentation and understanding the factors associated with it would help to tailor screening and information strategies for better efficiency. We performed a retrospective cohort study in Kinshasa, the capital of the DRC. The studied population included HIV-positive adults newly enrolled in HIV care between January 2006 and June 2020 at 25 HIV urban care facilities. Patient information collected at presentation for HIV care included age, sex, WHO clinical stage and screening context. We used 2 definitions of late presentation: the WHO definition of advanced HIV disease (WHO stage 3/4 or CD4 cell count < 200 cells/mm3) and a more inclusive definition (WHO stage 3/4 or CD4 cell count < 350 cells/mm3). RESULTS: A total of 10,137 HIV-infected individuals were included in the analysis. The median age was 40 years; 68% were female. A total of 45.9% or 47.5% of the patients were late presenters, depending on the definition used. The percentage of patients with late presentation (defined as WHO stage 3/4 or CD4 cell count < 350 cells/mm3) decreased during recent years, from 70.7% in 2013 to 46.5% in 2017 and 23.4% in 2020. Age was associated with a significantly higher risk of LP (p < 0.0001). We did not observe any impact of sex. CONCLUSIONS: The frequency of late presentation for care is decreasing in Kinshasa, DRC. Efforts have to be continued. In particular, the issue of late diagnosis in older individuals should be addressed.
INTRODUCTION: Late presentation for HIV care is a well-described issue for the success of ART outcomes and the cause of higher morbidity, mortality and further transmission. Monitoring the level of late presentation and understanding the factors associated with it would help to tailor screening and information strategies for better efficiency. We performed a retrospective cohort study in Kinshasa, the capital of the DRC. The studied population included HIV-positive adults newly enrolled in HIV care between January 2006 and June 2020 at 25 HIV urban care facilities. Patient information collected at presentation for HIV care included age, sex, WHO clinical stage and screening context. We used 2 definitions of late presentation: the WHO definition of advanced HIV disease (WHO stage 3/4 or CD4 cell count < 200 cells/mm3) and a more inclusive definition (WHO stage 3/4 or CD4 cell count < 350 cells/mm3). RESULTS: A total of 10,137 HIV-infected individuals were included in the analysis. The median age was 40 years; 68% were female. A total of 45.9% or 47.5% of the patients were late presenters, depending on the definition used. The percentage of patients with late presentation (defined as WHO stage 3/4 or CD4 cell count < 350 cells/mm3) decreased during recent years, from 70.7% in 2013 to 46.5% in 2017 and 23.4% in 2020. Age was associated with a significantly higher risk of LP (p < 0.0001). We did not observe any impact of sex. CONCLUSIONS: The frequency of late presentation for care is decreasing in Kinshasa, DRC. Efforts have to be continued. In particular, the issue of late diagnosis in older individuals should be addressed.
Authors: Gayle P Pouliot; James Degar; Laura Hinze; Bose Kochupurakkal; Chau D Vo; Melissa A Burns; Lisa Moreau; Chirag Ganesa; Justine Roderick; Sofie Peirs; Bjorn Menten; Mignon L Loh; Stephen P Hunger; Lewis B Silverman; Marian H Harris; Kristen E Stevenson; David M Weinstock; Andrew P Weng; Pieter Van Vlierberghe; Alan D D'Andrea; Alejandro Gutierrez Journal: PLoS One Date: 2019-11-13 Impact factor: 3.240
Authors: Amina Ait-Ammar; Anna Kula; Gilles Darcis; Roxane Verdikt; Stephane De Wit; Virginie Gautier; Patrick W G Mallon; Alessandro Marcello; Olivier Rohr; Carine Van Lint Journal: Front Microbiol Date: 2020-01-24 Impact factor: 5.640